Laboratoires DELBERT, SAS develops and manufactures medicines in fields, such as oncology, infectious diseases, psychiatry, and neurology; and manufactures medical device. It offers products for infectiology, such as ISTOPEN®, PENSTAPHO®, PROSTAPHLIN®, EXTENCILLINE® 1,2 MUI, EXTENCILLINE® 0,6 MUI, EXTENCILLINE® 2,4 MUI, AMUKIN® 500mg/2ml, and AMUKIN® 1g/4ml; oncology, which include OXYCODONE DELBERT®, OXYCODONE DELBERT@, OXYCODONE DELBERT®, OXYCODONE DELBERT®, VERCYTE®, and HEXASTAT®; psychiatry, which include PIPORTIL® L4, PIPORTIL®, and PIPORTIL® L4; pulmonology, such as ISTENDO®; and medical device, which includes BLEU DE METHYLENE. Laboratoires DELBERT, SAS was founded in 2002 and is based in Paris, France.